Remote Dielectric Sensing Before and After Discharge in Patients With ADHF: The ReDS-SAFE HF Trial.

Autor: Alvarez-Garcia J; Ramon y Cajal University Hospital, Madrid, Spain; Centro de Investigación en Red en Enfermedades Cardiovasculares, Madrid, Spain. Electronic address: jalvarezg82@gmail.com., Lala A; Mount Sinai Hospital, New York, New York, USA; Zena and Michael A. Wiener Cardiovascular Institute and Department of Population Health Science and Policy, Mount Sinai, New York, New York, USA. Electronic address: anu.lala@mountsinai.org., Rivas-Lasarte M; Centro de Investigación en Red en Enfermedades Cardiovasculares, Madrid, Spain; Puerta de Hierro Majadahonda University Hospital, Majadahonda, Madrid, Spain., De Rueda C; Ramon y Cajal University Hospital, Madrid, Spain; Centro de Investigación en Red en Enfermedades Cardiovasculares, Madrid, Spain., Brunjes D; Mount Sinai Hospital, New York, New York, USA; Zena and Michael A. Wiener Cardiovascular Institute and Department of Population Health Science and Policy, Mount Sinai, New York, New York, USA., Lozano-Jimenez S; Centro de Investigación en Red en Enfermedades Cardiovasculares, Madrid, Spain; Puerta de Hierro Majadahonda University Hospital, Majadahonda, Madrid, Spain., Garcia-Sebastian C; Ramon y Cajal University Hospital, Madrid, Spain; Centro de Investigación en Red en Enfermedades Cardiovasculares, Madrid, Spain., Mitter S; Mount Sinai Hospital, New York, New York, USA; Zena and Michael A. Wiener Cardiovascular Institute and Department of Population Health Science and Policy, Mount Sinai, New York, New York, USA., Remior P; Ramon y Cajal University Hospital, Madrid, Spain., Jimenez-Blanco Bravo M; Ramon y Cajal University Hospital, Madrid, Spain; Centro de Investigación en Red en Enfermedades Cardiovasculares, Madrid, Spain., Del Prado S; Ramon y Cajal University Hospital, Madrid, Spain; Centro de Investigación en Red en Enfermedades Cardiovasculares, Madrid, Spain., Barghash M; Mount Sinai Hospital, New York, New York, USA; Zena and Michael A. Wiener Cardiovascular Institute and Department of Population Health Science and Policy, Mount Sinai, New York, New York, USA., González-Ferrer E; Ramon y Cajal University Hospital, Madrid, Spain; Centro de Investigación en Red en Enfermedades Cardiovasculares, Madrid, Spain., Ullman J; Mount Sinai Hospital, New York, New York, USA; Zena and Michael A. Wiener Cardiovascular Institute and Department of Population Health Science and Policy, Mount Sinai, New York, New York, USA., Cobo M; Centro de Investigación en Red en Enfermedades Cardiovasculares, Madrid, Spain; Puerta de Hierro Majadahonda University Hospital, Majadahonda, Madrid, Spain., Segovia-Cubero J; Centro de Investigación en Red en Enfermedades Cardiovasculares, Madrid, Spain; Puerta de Hierro Majadahonda University Hospital, Majadahonda, Madrid, Spain., Zamorano JL; Ramon y Cajal University Hospital, Madrid, Spain; Centro de Investigación en Red en Enfermedades Cardiovasculares, Madrid, Spain., Pinney SP; Mount Sinai Hospital, New York, New York, USA; Zena and Michael A. Wiener Cardiovascular Institute and Department of Population Health Science and Policy, Mount Sinai, New York, New York, USA., Mancini D; Mount Sinai Hospital, New York, New York, USA; Zena and Michael A. Wiener Cardiovascular Institute and Department of Population Health Science and Policy, Mount Sinai, New York, New York, USA.
Jazyk: angličtina
Zdroj: JACC. Heart failure [JACC Heart Fail] 2024 Apr; Vol. 12 (4), pp. 695-706. Date of Electronic Publication: 2024 Feb 28.
DOI: 10.1016/j.jchf.2024.01.002
Abstrakt: Background: Incomplete treatment of congestion often leads to worsening heart failure (HF). The remote dielectric sensing (ReDS) system is an electromagnetic energy-based technology that accurately quantifies changes in lung fluid concentration noninvasively.
Objectives: This study sought to assess whether an ReDS-guided strategy during acutely decompensated HF hospitalization is superior to routine care for improving outcomes at 1 month postdischarge.
Methods: ReDS-SAFE HF (Use of ReDS for a SAFE discharge in patients with acute Heart Failure) was an investigator-initiated, multicenter, single-blind, randomized, proof-of-concept trial in which 100 patients were randomized to a routine care strategy, with discharge criteria based on current clinical practice, or an ReDS-guided decongestion strategy, with discharge criteria requiring an ReDS value of ≤35%. ReDS measurements were performed daily and at a 7-day follow-up visit, with patients and treating physicians in the routine care arm blinded to the results. The primary outcome was a composite of unplanned visits for HF, HF rehospitalization, or death at 1 month after discharge.
Results: The mean age was 67 ± 14 years, and 74% were male. On admission, left ventricular ejection fraction was 37% ± 16%, and B-type natriuretic peptide was 940 pg/L (Q1-Q3: 529-1,665 pg/L). The primary endpoint occurred in 10 (20%) patients in the routine care group and 1 (2%) in the ReDS-guided strategy group (log-rank P = 0.005). The ReDS-guided strategy group experienced a lower event rate, with an HR of 0.094 (95% CI: 0.012-0.731; P = 0.003), and a number of patients needed to treat of 6 to avoid an event (95% CI: 3-17), mainly resulting from a decrease in HF readmissions. The median length of stay was 2 days longer in the ReDS-guided group vs the routine care group (8 vs 6; P = 0.203).
Conclusions: A ReDS-guided strategy to treat congestion improved 1-month prognosis postdischarge in this proof-of-concept study, mainly because of a decrease of the number of HF readmissions. (Use of ReDS for a SAFE discharge in patients with acute Heart Failure [ReDS-SAFE HF]; NCT04305717).
Competing Interests: Funding Support and Author Disclosures Remote dielectric sensing equipment was loaned by Sensible Medical and Sorevan. Dr Alvarez-Garcia has received a research grant from the Private Foundation Daniel Bravo Andreu. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
(Copyright © 2024 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.)
Databáze: MEDLINE